 |
|||||
|
|||||
|
|||||
|
|||||
|
|||||
Previous Article | Next Article
The Journal of Neuroscience, January 1, 2000, 20(1):259-265
Proteasome Inhibitors Induce Cytochrome c-Caspase-3-Like Protease-Mediated Apoptosis in Cultured Cortical Neurons
Jian Hua Qiu1, Akio Asai1, 3, Shunji Chi1, 3, Nobuhito Saito1, Hirofumi Hamada2, and Takaaki Kirino1, 3 1 Laboratory for Neuroscience and Neurooncology, Faculty of Medicine, University of Tokyo, Tokyo, 113-8655 Japan, 2 Department of Molecular Biotherapy Research, Cancer Chemotherapy Center, Cancer Institute, Tokyo, 170-8455 Japan, and 3 CREST (Core Research for Evolutional Science and Technology), Japan Science and Technology Corporation, Kawaguchi, 332-0012 Japan
The ubiquitin-proteasome protein degradation pathway is crucial in controlling intracellular levels of a variety of short-lived proteins and maintaining cellular growth and metabolism. In a previous study, we showed the accumulation of conjugated ubiquitin in CA1 neurons of the gerbil after 5 min of forebrain ischemia (Morimoto et al., 1996; Ide et al., 1999). The accumulation of conjugated ubiquitin may reflect proteasome malfunction. In the present study, we investigated the effects of proteasome inhibitors on primary neuronal cultures to determine whether proteasomal malfunction induces neuronal death. When carbobenzoxy-Leu-Leu-Leu-aldehyde or lactacystin, two different types of proteasome inhibitors, were separately used to suppress proteasome activity, we observed induction of apoptotic neuronal cell death in both cases. During the apoptotic process, mitochondrial membrane potential was disrupted, cytochrome-c was released from mitochondria into the cytosol, and caspase-3-like proteases were activated. Apoptosis was inhibited by pretreatment with acetyl-aspartyl-glutamyl-valyl-aspart-1-aldehyde or overexpression of Bcl-x/L. These results demonstrated that suppression of proteasome function induces neuronal apoptosis via the release of cytochrome c from mitochondria and activation of caspase-3-like proteases.
Key words: neuron; apoptosis; proteasome; cytochrome c; caspase-3-like proteases; ubiquitin
Copyright © 2000 Society for Neuroscience 0270-6474/0/201259-07$05.00/0
This article has been cited by other articles:
R. Meller
The Role of the Ubiquitin Proteasome System in Ischemia and Ischemic Tolerance
Neuroscientist, June 1, 2009; 15(3): 243 - 260.
[Abstract] [PDF]
M. A. Gitcho, J. Strider, D. Carter, L. Taylor-Reinwald, M. S. Forman, A. M. Goate, and N. J. Cairns
VCP Mutations Causing Frontotemporal Lobar Degeneration Disrupt Localization of TDP-43 and Induce Cell Death
J. Biol. Chem., May 1, 2009; 284(18): 12384 - 12398.
[Abstract] [Full Text] [PDF]
Z. G. Hu, H. D. Wang, W. Jin, and H. X. Yin
Ketogenic Diet Reduces Cytochrome c Release and Cellular Apoptosis Following Traumatic Brain Injury in Juvenile Rats
Ann. Clin. Lab. Sci., January 1, 2009; 39(1): 76 - 83.
[Abstract] [Full Text] [PDF]
F. Zhang, A. J. Paterson, P. Huang, K. Wang, and J. E. Kudlow
Metabolic Control of Proteasome Function
Physiology, December 1, 2007; 22(6): 373 - 379.
[Abstract] [Full Text] [PDF]
S. Mulugeta, J. A. Maguire, J. L. Newitt, S. J. Russo, A. Kotorashvili, and M. F. Beers
Misfolded BRICHOS SP-C mutant proteins induce apoptosis via caspase-4- and cytochrome c-related mechanisms
Am J Physiol Lung Cell Mol Physiol, September 1, 2007; 293(3): L720 - L729.
[Abstract] [Full Text] [PDF]
Q. Ding, E. Dimayuga, W. R. Markesbery, and J. N. Keller
Proteasome inhibition induces reversible impairments in protein synthesis
FASEB J, June 1, 2006; 20(8): 1055 - 1063.
[Abstract] [Full Text] [PDF]
B. Tremper-Wells and M. L. Vallano
Nuclear Calpain Regulates Ca2+-dependent Signaling via Proteolysis of Nuclear Ca2+/Calmodulin-dependent Protein Kinase Type IV in Cultured Neurons
J. Biol. Chem., January 21, 2005; 280(3): 2165 - 2175.
[Abstract] [Full Text] [PDF]
H. J. Rideout, P. Dietrich, Q. Wang, W. T. Dauer, and L. Stefanis
{alpha}-Synuclein Is Required for the Fibrillar Nature of Ubiquitinated Inclusions Induced by Proteasomal Inhibition in Primary Neurons
J. Biol. Chem., November 5, 2004; 279(45): 46915 - 46920.
[Abstract] [Full Text] [PDF]
C. Wojcik and M. Di Napoli
Ubiquitin-Proteasome System and Proteasome Inhibition: New Strategies in Stroke Therapy
Stroke, June 1, 2004; 35(6): 1506 - 1518.
[Abstract] [Full Text] [PDF]
E. M. Valente, P. M. Abou-Sleiman, V. Caputo, M. M. K. Muqit, K. Harvey, S. Gispert, Z. Ali, D. Del Turco, A. R. Bentivoglio, D. G Healy, et al.
Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
Science, May 21, 2004; 304(5674): 1158 - 1160.
[Abstract] [Full Text] [PDF]
P. G. Sullivan, N. B. Dragicevic, J.-H. Deng, Y. Bai, E. Dimayuga, Q. Ding, Q. Chen, A. J. Bruce-Keller, and J. N. Keller
Proteasome Inhibition Alters Neural Mitochondrial Homeostasis and Mitochondria Turnover
J. Biol. Chem., May 14, 2004; 279(20): 20699 - 20707.
[Abstract] [Full Text] [PDF]
N. R. Jana, P. Dikshit, A. Goswami, and N. Nukina
Inhibition of Proteasomal Function by Curcumin Induces Apoptosis through Mitochondrial Pathway
J. Biol. Chem., March 19, 2004; 279(12): 11680 - 11685.
[Abstract] [Full Text] [PDF]
H. Sawada, R. Kohno, T. Kihara, Y. Izumi, N. Sakka, M. Ibi, M. Nakanishi, T. Nakamizo, K. Yamakawa, H. Shibasaki, et al.
Proteasome Mediates Dopaminergic Neuronal Degeneration, and Its Inhibition Causes {alpha}-Synuclein Inclusions
J. Biol. Chem., March 12, 2004; 279(11): 10710 - 10719.
[Abstract] [Full Text] [PDF]
L. M. Mandrusiak, L. K. Beitel, X. Wang, T. C. Scanlon, E. Chevalier-Larsen, D. E. Merry, and M. A. Trifiro
Transglutaminase potentiates ligand-dependent proteasome dysfunction induced by polyglutamine-expanded androgen receptor
Hum. Mol. Genet., July 1, 2003; 12(13): 1497 - 1506.
[Abstract] [Full Text] [PDF]
H. J. Rideout, Q. Wang, D. S. Park, and L. Stefanis
Cyclin-Dependent Kinase Activity Is Required for Apoptotic Death But Not Inclusion Formation in Cortical Neurons after Proteasomal Inhibition
J. Neurosci., February 15, 2003; 23(4): 1237 - 1245.
[Abstract] [Full Text] [PDF]
M. Lesort, M. Lee, J. Tucholski, and G. V. W. Johnson
Cystamine Inhibits Caspase Activity. IMPLICATIONS FOR THE TREATMENT OF POLYGLUTAMINE DISORDERS
J. Biol. Chem., January 31, 2003; 278(6): 3825 - 3830.
[Abstract] [Full Text] [PDF]
E. Junn, S. S. Lee, U. T. Suhr, and M. M. Mouradian
Parkin Accumulation in Aggresomes Due to Proteasome Impairment
J. Biol. Chem., November 27, 2002; 277(49): 47870 - 47877.
[Abstract] [Full Text] [PDF]
J. Araya, M. Maruyama, A. Inoue, T. Fujita, J. Kawahara, K. Sassa, R. Hayashi, Y. Kawagishi, N. Yamashita, E. Sugiyama, et al.
Inhibition of proteasome activity is involved in cobalt-induced apoptosis of human alveolar macrophages
Am J Physiol Lung Cell Mol Physiol, October 1, 2002; 283(4): L849 - L858.
[Abstract] [Full Text] [PDF]
H.-K. Lin, S. Altuwaijri, W.-J. Lin, P.-Y. Kan, L. L. Collins, and C. Chang
Proteasome Activity Is Required for Androgen Receptor Transcriptional Activity via Regulation of Androgen Receptor Nuclear Translocation and Interaction with Coregulators in Prostate Cancer Cells
J. Biol. Chem., September 20, 2002; 277(39): 36570 - 36576.
[Abstract] [Full Text] [PDF]
H. Nishitoh, A. Matsuzawa, K. Tobiume, K. Saegusa, K. Takeda, K. Inoue, S. Hori, A. Kakizuka, and H. Ichijo
ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats
Genes & Dev., June 1, 2002; 16(11): 1345 - 1355.
[Abstract] [Full Text] [PDF]
Q. Ding, J. J. Lewis, K. M. Strum, E. Dimayuga, A. J. Bruce-Keller, J. C. Dunn, and J. N. Keller
Polyglutamine Expansion, Protein Aggregation, Proteasome Activity, and Neural Survival
J. Biol. Chem., April 12, 2002; 277(16): 13935 - 13942.
[Abstract] [Full Text] [PDF]
M. Stanciu and D. B. DeFranco
Prolonged Nuclear Retention of Activated Extracellular Signal-regulated Protein Kinase Promotes Cell Death Generated by Oxidative Toxicity or Proteasome Inhibition in a Neuronal Cell Line
J. Biol. Chem., February 1, 2002; 277(6): 4010 - 4017.
[Abstract] [Full Text] [PDF]
F. M. S. DE VRIJ, J. A. SLUIJS, L. GREGORI, D. F. FISCHER, W. T. J. M. C. HERMENS, D. GOLDGABER, J. VERHAAGEN, F. W. VAN LEEUWEN, and E. M. HOL
Mutant ubiquitin expressed in Alzheimer's disease causes neuronal death1
FASEB J, December 1, 2001; 15(14): 2680 - 2688.
[Abstract] [Full Text] [PDF]
N. R. Jana, E. A. Zemskov, G.-h. Wang, and N. Nukina
Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release
Hum. Mol. Genet., May 1, 2001; 10(10): 1049 - 1059.
[Abstract] [Full Text] [PDF]
K. Breitschopf, A. M. Zeiher, and S. Dimmeler
Ubiquitin-mediated Degradation of the Proapoptotic Active Form of Bid. A FUNCTIONAL CONSEQUENCE ON APOPTOSIS INDUCTION
J. Biol. Chem., July 7, 2000; 275(28): 21648 - 21652.
[Abstract] [Full Text] [PDF]
|
|
|
|
 |
|